Stay updated with breaking news from Yonjin Venture. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- OncoResponse, a clinical-stage biotech company advancing immunotherapies derived from the immune systems of Elite Cancer Responders, today...
HistoSonics announced today that it raised $85 million in a financing round led by Johnson & Johnson Innovation.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Amid an overall pullback in capital markets, investors and entrepreneurs continue to find ways to make deals work. Case-in-point: HistoSonics Inc.The Ann Arbor-based medical device company that's developing a non-invasive ultrasound therapy that can destroy cancer tumors has closed on an $85…
Financings Planned to Support Rapid Expansion of Histotripsy Platform as Company Welcomes Silk Road Medical CEO, Erica Rogers, to its Board of Directors MINNEAPOLIS, Dec. 13, 2022 /PRNewswire/